Back to comparisons

Comparison

NMN vs Pycnogenol (Maritime Pine Bark)

FieldNMNPycnogenol (Maritime Pine Bark)
Categoryneuroprotectiveneuroprotective
Dose range250–1000mg100–200mg
Half-life
Onset
EvidenceEVIDENCEBEVIDENCEB
Safety●●●●●●●●●●
Legal (US)USOTCUSOTC
PubMed refs600580

The comparison in plain English

Auto-generated from data

NMN and Pycnogenol (Maritime Pine Bark) are both in the neuroprotective category respectively. NMN Nicotinamide mononucleotide — NAD+ precursor. Pycnogenol (Maritime Pine Bark) Branded extract of French maritime pine bark.

Bottom line

NMN (evidence B, safety 5/5) matches the evidence base of Pycnogenol (Maritime Pine Bark) (evidence B, safety 5/5). NMN has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.

Choose NMN if

NMN is the better fit when your goal aligns with its mechanism (Direct precursor to NAD+ — one biosynthetic step closer than nicotinamide riboside, bypassing the NRK1/NRK2 enzymatic step) and the dose range (250–1000mg) suits your protocol. Half-life is —h.

Choose Pycnogenol (Maritime Pine Bark) if

Pycnogenol (Maritime Pine Bark) is the better fit when your goal aligns with its mechanism (A complex of procyanidins (oligomeric proanthocyanidins), bioflavonoids, and organic acids) and the dose range (100–200mg) suits your protocol. Half-life is —h.

Build a stack with bothOpen builder →
Check interactionsOpen checker →